https://ir.corbuspharma.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_dc5231ac157b9ee4fb322b64fcb7a082/corbuspharma/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.corbuspharma.com/news-events/press-releases/detail/470/corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference-call Thu, 21 May 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/470/corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference-call https://ir.corbuspharma.com/news-events/press-releases/detail/469/corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors Thu, 14 May 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/469/corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors https://ir.corbuspharma.com/news-events/press-releases/detail/468/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences Wed, 13 May 26 07:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/468/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences https://ir.corbuspharma.com/news-events/press-releases/detail/467/corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update Tue, 12 May 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/467/corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update https://ir.corbuspharma.com/news-events/press-releases/detail/466/corbus-pharmaceuticals-to-host-in-person-and-virtual-kol-event-at-asco-2026 Tue, 05 May 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/466/corbus-pharmaceuticals-to-host-in-person-and-virtual-kol-event-at-asco-2026 https://ir.corbuspharma.com/news-events/press-releases/detail/465/corbus-pharmaceuticals-announces-abstracts-accepted-for-presentation-at-asco-2026-featuring-updated-clinical-data-for-crb-701 Wed, 22 Apr 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/465/corbus-pharmaceuticals-announces-abstracts-accepted-for-presentation-at-asco-2026-featuring-updated-clinical-data-for-crb-701 https://ir.corbuspharma.com/news-events/press-releases/detail/464/corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity Tue, 14 Apr 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/464/corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity https://ir.corbuspharma.com/news-events/press-releases/detail/463/corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer Tue, 07 Apr 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/463/corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer https://ir.corbuspharma.com/news-events/press-releases/detail/462/corbus-pharmaceuticals-to-participate-in-the-bmo-2026-metabolic-health-summit Wed, 18 Mar 26 08:00:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/462/corbus-pharmaceuticals-to-participate-in-the-bmo-2026-metabolic-health-summit https://ir.corbuspharma.com/news-events/press-releases/detail/461/corbus-pharmaceuticals-reports-q4-and-2025-financial-results-and-provides-a-corporate-update Mon, 09 Mar 26 07:30:00 -0400 https://ir.corbuspharma.com/news-events/press-releases/detail/461/corbus-pharmaceuticals-reports-q4-and-2025-financial-results-and-provides-a-corporate-update